Dr. François Lellouche is critical care physician at the Institut universitaire de cardiologie et de pneumologie de Québec and associate professor at the Faculté de médecine at Université Laval. His research interests include humidification of gas during mechanical ventilation, non-invasive mechanical ventilation, high-flow oxygen therapy and new modes of mechanical ventilation, focusing on automated modes of respiratory support and closed-loop oxygen supplementation. He conducts bench studies at the research centre of the Institut universitaire de cardiologie et de pneumologie de Québec, physiological studies focusing on breathing physiology and clinical trials to evaluate the clinical impact based on preliminary studies. His laboratory develops several innovative devices in the field of respiratory and oxygen support, including the FreeO2 device, a new breakthrough closed-loop device that titrates oxygen flow based on patient needs. He co-founded the Oxynov company that manufactures and commercializes the FreeO2 device in Europe and Canada. He is currently PI of several studies focusing on COVID-19 management including a CIHR-funded multicentric study on automated oxygen titration to reduce healthcare worker interventions and a pilot study on new COVID treatments.